Pharmaceuticals, Biotechnology and Life Sciences
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based…
NASHVILLE, Tenn.–(BUSINESS WIRE)–#mediledger—Cumberland announced today that it has joined forces with Chronicled as a preferred systems integration partner for the…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Clinicaltrials–Please note the Hope Biosciences boilerplate has been updated. The corrected release reads: VIRTRIAL AWARDED FDA-APPROVED DECENTRALIZED CLINICAL…
The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research,…
BEACHWOOD, Ohio–(BUSINESS WIRE)–Many patients rely on copay cards and coupons from pharmaceutical companies to manage the out of pocket cost…
– Intravitreal ANX007 was well-tolerated and demonstrated full target engagement and inhibition of C1q in the eye for at least…
Gelest exclusive supplier of chemistry for OcuMedic proprietary drug eluting contact lens and corneal bandage MULLICA HILL, N.J.–(BUSINESS WIRE)–#Cornea—OcuMedic, Inc.,…
Reena Sharma, MD will serve as EU Coordinating Investigator for Extension Protocol ALACHUA, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), formerly…
Davie Succeeds David Grange, Positioning Organization for Continued Growth HOUSTON–(BUSINESS WIRE)–Pharm-Olam, a global midsized CRO, today announced that the company’s…